Build Program

8VC is a firm built by founders for founders. Entrepreneurial DNA is one of our core values.

Our partners have built companies from the ground up, and we understand what it takes to succeed across industries and verticals. The 8VC Build Program leverages our background as entrepreneurs, vantage point as investors, and powerful talent network to launch companies to address conceptual gaps in the market.

The virtuous circle of
investing and building

Through the investment process, we often identify whitespaces and internal theses where there are opportunities to remedy an important part of the world.

We gain exposure through our work to determine the optimal approach to add value, often by tackling messy, legacy technical systems in industries paralyzed by their scale. The Build program creates a powerful channel for 8VC to act on these ideas, partnering with ambitious entrepreneurs and engineers, and creating positive feedback loops as we build sustainable businesses. 8VC Build companies are either initially driven by these internal theses or our Entrepreneurs-in-Residence, who join 8VC with a problem, technology, or vertical in mind.

8VC Founder and serial entrepreneur Joe Lonsdale is personally involved with each of the 8VC Build companies, helping to craft their theses and guide strategy. Partners across the firm work directly with our founders in the Build process to give our companies unfair advantages.

Our build companies are tackling hard problems across a range of industry sectors

Maleka Momand
Zachary Bookman
Alex Moore
Brian Hendrickson
Zivan Benisty
Charlie Songhurst
Justin Rockefeller
Blake Brickman
Jake Medwell
Shaleen Devgun
David Wyler
Alan Gershenhorn
Chris Sultemeier
Justin Hall
Dan Faga
Daniel Saks
Alicia Jackson
Lawrence Fong, MD
Arie Belldegrun, MD
Andrew Rubin
Cameron Sepah
Andrew Perlman
Jonathan Weissman, PhD
Dan Widmaier
25
Harrison T. LeFrak
25
Jerry Yang
25
Scott Cook
25
Greg Silverman
25
Keri Findley
25
John Mack
25
Isaac Applbaum
25
Vivian Bannon
25
Eric Poirier

Build companies are part of a broader 8VC context, including portfolio companies and advisors

Our build companies are tackling hard problems across a range of industry sectors

Stage

Series C

Founded

2017

[Overview]

Epirus is the only U.S. developer of software-defined high-powered electromagnetic pulse (“EMP”) technology. The nature of warfare has changed and our military is outdated. Dynamic threats, particularly drone swarms, to critical infrastructure, nuclear sites, airports, stadiums and mass gatherings are increasing and creating havoc around the globe. Through Epirus’ initial focus on EMP in defense, their best-in-class team’s innovation unlocked major advancements in smart and on-chip AI to control power applications beyond defense to commercial applications, driving financial savings and reducing radical power consumption and emissions.

[How was it built]

8VC helped to build a company around incredible technical talent, from the formation of an exemplary leadership team to helping build a culture of highly autonomous problem-solving and resolve. Co-founder and CTO Bo Marr is the father of next-generation EMP and has written many of the most important patents in the space.  CEO Leigh Madden was a U.S. Navy SEAL who built Microsoft’s National Security and Defense business to over $1.5B annually, winning landmark contracts including the $10B DoD’s Joint Enterprise Defense Infrastructure (“JEDI”) contract.  CFO Ken Bedingfield was most recently CFO of Northrop Grumman.  Co-Founder and Executive Chairman Grant Verstandig is an entrepreneur (sold Rally Health for $7b to United Health), investor and advisor to multiple government organizations, including serving as a senior advisor to the National Security Agency on advanced analytics, technology, and Artificial Intelligence. Epirus also gathered together some of the best talent in the industry in the quest to build the best power management solutions on chips with AI for their EMP defense product.

[Results]

Epirus’ SmartPower platform, which uses AI to generate massive power output as needed and without special cooling, is now the most power-dense phased array in existence, creating new opportunities for intelligent power products in commercial markets. Epirus is architecting the future of defense through its software-defined directed energy products, which have demonstrated the ability to take down drone swarms from over 1 km away. The company recently closed a $200MM Series C, bringing its total financing to $287 million, with a valuation of $1.35 billion.

Stage

Series D

Founded

2020

[Overview]

Resilience is building the future of biomedicine manufacturing, dramatically increasing production capacity for pioneering novel treatment modalities, ensuring that medicines are accessible to all patients and protecting against supply chain disruptions.

[How was it built]

As the world reeled from at the outset of the global COVID-19 pandemic, our firm worked deeply to strategize what we should do for society. Through those sessions in conjunction with ARCH Ventures, the thesis emerged that we needed to remedy critical vulnerabilities in medical supply chains. Together, Bob Nelsen and Joe Lonsdale founded Resilience and raised $800MM to create capabilities and capacity to rapidly produce and distribute important drugs at scale. Together, we amassed top executives, Board of Directors, and advisors with experience at the highest levels of business, the biopharmaceutical industry, academia, and government, including:– Rahul Singhvi, Sc.D. — CEO; former Operating Partner at Flagship Pioneering; COO of Takeda Vaccines; CEO of Novavax– Sandy Mahatme, LL.M. — President, COO & CFO; former CFO and Chief Business Officer at Sarepta Therapeutics; SVP Finance & Corporate Development at Celgene– Patrick Y. Yang, Ph.D. — Vice Chairman; former EVP at Juno Therapeutics; EVP & Global Head of Technical Operations at Roche/GenentechDirectors and Advisors include luminaries such as Frances Arnold, the Nobel Prize-winning professor from the California Institute of Technology; George Barrett, the former chief executive of Cardinal Health; Susan Desmond-Hellmann, the former president of product development at Genentech; Kaye Foster, the former vice president of human resources at Johnson and Johnson; and Denice Torres, the former president of Johnson & Johnson Pharmaceutical and Consumer Companies; and more.

[Results]

Since its founding, Resilience has launched ten integrated operational facilities, spanning 1 million square feet of manufacturing space and over 1,600 employees. Recent highlights include the announcement of a joint venture with MD Anderson to accelerate development and manufacturing of cell therapies for cancer. In June 2022, Resilience raised a $625MM Series D.

Stage

Series A

Founded

2018

[Overview]

Standard Metrics is building a proprietary data platform and network for the private markets, creating new standards of governance and transparency to enable deeper collaboration between start-ups and VCs.

[How was it built]

The idea for Standard Metrics was born at 8VC to address our own pain-points in tracking portfolio company metrics.  The co-founders began working together on an initial proof-of-concept alongside 8VC partners Joe Lonsdale and Alex Moore and the rest of the partnership.  Co-founder Kevin Hsu was an early employee and PM at Carta before joining 8VC as an EIR; co-founder Deny Khoung helped spin-out and advise several portfolio companies (including Affinity) as 8VC’s Director of Design; John Melas-Kyriazi joined Standard Metrics as co-founder and CEO after five years as a Partner at Spark Capital.

[Results]

While 8VC served as Standard Metrics' first pilot customer, the team has now onboarded over a thousand companies to the platform. In early 2022, Standard Metrics raised a $23.7MM Series A.

20

Companies founded since 2016 valued at over $10 billion

view
view
Financial Services
view
view
Financial Services
Smart Enterprise
view
view
Government & Defense
view
view
Government & Defense
view
view
Government & Defense
Government & Defense
view
view
Consumer
view
view
view
view
Life Sciences
view
view
Life Sciences
view
view
Financial Services
view
view
Life Sciences
view
view

What we stand by

Whether through the Build program or our broader portfolio and community,
we cultivate deep relationships with talented founders.

Entrepreneurs-in-Residence (EIR) work directly with 8VC’s partners and within 8VC’s network to hone in on industry-upsetting Build company ideas.

View jobs
View Jobs
No items found.
No items found.

Our build companies are tackling hard problems across a range of industry sectors

Works after the site is published

Build companies are part of a broader 8VC context, including portfolio companies and advisors